Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent and VitaFlow valve
Sponsored by MicroPort
Other coronary interventions
Stents and scaffolds
TAVI
Coronary Interventions
Interventions for Valvular Disease
Join us if you want
- To learn the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools
- To learn the features and benefits of PCI robot R-ONE and first clinical trial updates in China
- To learn the five-year clinical results of VitaFlow Transcatheter Aortic Valve System
Anchorperson: Andreas Baumbach
Moderator: Pieter Smits
Discussant: Bo Xu
Chatmaster: Wei Liu
Speakers: Yundai Chen, Mao Chen, Ling Tao
Session objectives
Andreas Baumbach
PCI Robot R-ONE: progress from the China pivotal study
Yundai Chen
Discussion and audience interaction
Firehawk stent in STEMI: primary endpoint results from TARGET STEMI OCT China trial
Ling Tao
Discussion and audience interaction
VitaFlow in severe aortic stenosis patient: five-year clinical outcomes
Mao Chen
Discussion and audience interaction
Session evaluation and key learnings
Pieter Smits
